Definitive Contract 75N91021C00050
Award Date
9/16/21
Potential Completion Date
12/15/22
Potential Value
$400K
Federal Agency
National Cancer Institute
Awardee
Pieces Technologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a $300,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Coordination Pharmaceuticals Inc., a small business. The contract is for the detection, diagnosis, treatment, prevention, and research of pediatric cancers and/or rare cancers. It was awarded under a Small Business Innovation Research (SBIR) Concept Award Program, which is a "Phase 0" pilot program intended to encourage small businesses to develop innovative and...
This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This is a $399,870 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Apricity Health LLC, a small business based in Houston, Texas. The contract is for the development of "Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement" under a total small business set-aside solicitation. The original solicitation, PHS-2020-1, sought proposals from small businesses for SBIR...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This federal contract award for $389,535 was made to Electronic Biosciences, Inc., a small business biotechnology company, by the National Cancer Institute (NCI) under the Small Business Innovation Research (SBIR) program. The contract is for the development of an "IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING" solution, which aligns with NCI's mission to support innovative technologies for cancer diagnostics and prevention. The contract is a Firm Fixed Price, Definitive...